CVS/$CVS
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About CVS
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
Ticker
$CVS
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
259,500
ISIN
US1266501006
Website
CVS Metrics
BasicAdvanced
$85B
16.12
$4.19
0.60
$2.66
3.94%
Price and volume
Market cap
$85B
Beta
0.6
52-week high
$72.51
52-week low
$43.56
Average daily volume
8.7M
Dividend rate
$2.66
Financial strength
Current ratio
0.823
Quick ratio
0.588
Long term debt to equity
95.492
Total debt to equity
105.321
Dividend payout ratio (TTM)
63.88%
Interest coverage (TTM)
3.12%
Profitability
EBITDA (TTM)
13,947
Gross margin (TTM)
13.54%
Net profit margin (TTM)
1.40%
Operating margin (TTM)
2.50%
Effective tax rate (TTM)
27.01%
Revenue per employee (TTM)
$1,450,000
Management effectiveness
Return on assets (TTM)
2.31%
Return on equity (TTM)
6.93%
Valuation
Price to earnings (TTM)
16.124
Price to revenue (TTM)
0.226
Price to book
1.11
Price to tangible book (TTM)
-2.09
Price to free cash flow (TTM)
14.324
Free cash flow yield (TTM)
6.98%
Free cash flow per share (TTM)
471.79%
Dividend yield (TTM)
3.94%
Forward dividend yield
3.94%
Growth
Revenue change (TTM)
4.75%
Earnings per share change (TTM)
-26.59%
3-year revenue growth (CAGR)
8.04%
10-year revenue growth (CAGR)
10.17%
3-year earnings per share growth (CAGR)
-11.47%
10-year earnings per share growth (CAGR)
0.27%
3-year dividend per share growth (CAGR)
9.07%
10-year dividend per share growth (CAGR)
8.51%
What the Analysts think about CVS
Analyst ratings (Buy, Hold, Sell) for CVS stock.
Bulls say / Bears say
CVS Health raised its full-year 2025 profit forecast to $6.00–$6.20 per share, up from the previous estimate of $5.75–$6.00, indicating strong financial recovery. (reuters.com)
The company reported a first-quarter adjusted profit of $2.25 per share, surpassing the estimated $1.70, reflecting effective cost-cutting measures and improved operational efficiency. (reuters.com)
CVS Health's pharmacy revenue increased to $31.91 billion, exceeding expectations and demonstrating robust performance in its core business segment. (reuters.com)
Activist investor Glenview Capital reduced its stake in CVS Health by 3.75 million shares, potentially signaling concerns about the company's long-term growth prospects. (reuters.com)
CVS Health's Chief Financial Officer, Thomas Cowhey, plans to step down amid ongoing turnaround efforts, which may indicate internal challenges and could affect investor confidence. (reuters.com)
The company reduced employee bonuses due to lower profit levels in 2024, reflecting financial struggles and potential difficulties in maintaining profitability. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 27 May 2025.
CVS Financial Performance
Revenues and expenses
CVS Earnings Performance
Company profitability
CVS News
AllArticlesVideos
Attorney General Liz Murrill files three lawsuits against CVS for unlawful practices
Reuters·18 hours ago
US health chief Kennedy met with insurers on prior authorization requirements
Reuters·2 days ago
UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?
Benzinga·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CVS stock?
CVS (CVS) has a market cap of $85B as of June 25, 2025.
What is the P/E ratio for CVS stock?
The price to earnings (P/E) ratio for CVS (CVS) stock is 16.12 as of June 25, 2025.
Does CVS stock pay dividends?
Yes, the CVS (CVS) stock pays dividends to shareholders. As of June 25, 2025, the dividend rate is $2.66 and the yield is 3.94%. CVS has a payout ratio of 63.88% on a trailing twelve-month basis.
When is the next CVS dividend payment date?
The next CVS (CVS) dividend payment date is unconfirmed.
What is the beta indicator for CVS?
CVS (CVS) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.